Request for biliary drainage for IgG4-SC could be waived before steroid administration?

Area of Science:

• Hepatology
• Gastroenterology
• Immunology

Background:

• IgG4-related sclerosing cholangitis (IgG4-SC) is a chronic fibrosing inflammatory condition.
• The role of biliary drainage (BD) in managing IgG4-SC is not well-established.

Purpose of the Study:

• To retrospectively evaluate the necessity of BD in IgG4-SC patients.
• To compare liver damage and jaundice improvement with and without BD before steroid therapy.

Main Methods:

• Retrospective analysis of 52 IgG4-SC patients.
• Propensity score matching used for patient selection (28 patients, 14 per group).
• Study endpoints: normalization rates of alkaline phosphatase (ALP) and total bilirubin (T-Bil) after 8 weeks of steroids.

Main Results:

• No significant difference in mean ALP or T-Bil between BD and non-BD groups before treatment.
• Similar ALP improvement rates (69.2% vs. 61.5%) and 100% T-Bil improvement rates in both groups after 8 weeks of steroids.
• Steroid therapy demonstrated efficacy in improving liver parameters regardless of BD.

Conclusions:

• Steroids are effective in treating liver damage and jaundice in IgG4-SC.
• Biliary drainage may not be essential for improving jaundice in IgG4-SC patients receiving steroids.